News | October 09, 2022
BioMarin simplifies organizational structure to increase efficiency
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
The company increases its efficiency and is able to face the growing demand for its services.
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
The inspection concluded with no observation (FDA-483) issued.
Subscribe To Our Newsletter & Stay Updated
